Cardiac disease is a condition that involves narrowing or blockage of blood vessels. Cardiac disease is caused due to heart rhythm problems, smoking, high cholesterol, and high blood pressure. Coronary artery disease, myocardial infarction, peripheral arterial disease, atherosclerosis, and heart failure are some of the major cardiac diseases. The contraction or obstruction of blood vessels, especially coronary arteries, is one of the most common reasons for cardiac diseases. Cardiovascular implants are widely used for the treatment of cardiac diseases.
The cardiac rhythm management devices segment is likely to expand at a rapid pace during the forecast period, due to increase in life expectancy and technological developments such as cardiac resynchronization therapy. Moreover, cardiac rhythm management devices are increasingly used for the management of arrhythmia and heart failure. In terms of end-user, the global market can be categorized into hospitals, ambulatory surgical centers, and research institutes. The hospitals segment is expected to expand at a high CAGR during the forecast period, as most patients prefer to visit hospitals for diagnosis and treatment. Moreover, larger number of cardiac implanted surgeries are conducted in hospitals. Prevalence of heart disorders and aging population are the major factors fueling the growth of the global cardiovascular implants market. Moreover, rise in awareness about these implants and established infrastructure are projected to drive the market during the forecast period. However, high cost of devices and stringent approval process are anticipated to restrain the market in the next few years.
The global Cardiovascular Implants market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cardiovascular Implants volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiovascular Implants market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Abbott Laboratories
Boston Scientific
Medtronic
St. Jude Medical
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Coronary Stents
Peripheral Stents
Heart Valves
Implanted Cardiac Pacemakers
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Therapy (CRT) Device
Segment by Application
Minimally Invasive Heart Surgery
Heart Valve Repair or Replacement
Cardiac Resynchronization Therapy (CRT)
Open Heart Surgery
Others
Table of Contents
Executive Summary
1 Cardiovascular Implants Market Overview
1.1 Product Overview and Scope of Cardiovascular Implants
1.2 Cardiovascular Implants Segment by Type
1.2.1 Global Cardiovascular Implants Production Growth Rate Comparison by Type (2014-2025)
Summary: Get latest Market Research Reports on Cardiovascular Implants . Industry analysis & Market Report on Cardiovascular Implants is a syndicated market report, published as Global Cardiovascular Implants Market Research Report 2019. It is complete Research Study and Industry Analysis of Cardiovascular Implants market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.